Alzamend Neuro Stock Quote ALZN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.6336

Bid

0.64

Ask

0.665

Volume

0.00 Day's Range 0.00

0.4388 52 Week Range 11.91

Market Cap

4.486M

Previous Close

0.6336

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

85,245

Shares Outstanding

7,120,703

Dividend Yield

PE Ratio

-0.30

Earnings Per Share (EPS)

-2.09

Revenue

Net Profit

-14.88M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $0.63. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.4388 to $ 11.91.

Alzamend Neuro currently has 7,120,703 shares outstanding. The market capitalization of Alzamend Neuro is $4.49 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.30.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0936	17.3333333333	0.54	0.73	0.4894	157170	0.59577628	CS
4	-0.0664	-9.48571428571	0.7	0.78	0.4388	103867	0.59843743	CS
12	-0.2524	-28.4875846501	0.886	1.29	0.4388	85245	0.8454424	CS
26	-1.0764	-62.9473684211	1.71	1.92	0.4388	110629	1.07402915	CS
52	-6.8664	-91.552	7.5	11.91	0.4388	151778	3.86746701	CS
156	-434.3664	-99.8543448276	435	503.25	0.4388	1194189	41.89231855	CS
260	-434.3664	-99.8543448276	435	503.25	0.4388	1194189	41.89231855	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.37 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 65.09 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.91 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.4599 (0.00%)	0
AACGATA Creativity Global	$ 0.91 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.37 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 65.09 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.91 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.4599 (0.00%)	0
AACGATA Creativity Global	$ 0.91 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.37 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 65.09 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.91 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 11.4599 (0.00%)	0
AACGATA Creativity Global	$ 0.91 (0.00%)	0